- AI
- Arbitration
- Asia
- Automobile
- Bangladesh
- Banking
- Biodiversity
- Biological Inventions
- bLAWgathon
- Brand Valuation
- Business
- Celebrity Rights
- Company Act
- Company Law
- Competition Law
- Constitutional Law
- Consumer Law
- Consumer Protection Authority
- Copyright
- Copyright Infringement
- Copyright Litigation
- Corporate Law
- Counterfeiting
- Covid
- Design
- Digital Media
- Digital Right Management
- Dispute
- Educational Conferences/ Seminar
- Environment Law Practice
- ESIC Act
- EX-Parte
- Farmer Right
- Fashion Law
- FDI
- FERs
- Foreign filing license
- Foreign Law
- Gaming Industry
- GDPR
- Geographical Indication (GI)
- GIg Economy
- Hi Tech Patent Commercialisation
- Hi Tech Patent Litigation
- IBC
- India
- Indonesia
- Intellectual Property
- Intellectual Property Protection
- IP Commercialization
- IP Licensing
- IP Litigation
- IP Practice in India
- IPAB
- IPAB Decisions
- IT Act
- IVF technique
- Judiciary
- Khadi Industries
- labour Law
- Legal Case
- Legal Issues
- Lex Causae
- Licensing
- Live-in relationships
- Lok Sabha Bill
- Marriage Act
- Maternity Benefit Act
- Media & Entertainment Law
- Mediation Act
- Member of Parliament
- Mergers & Acquisition
- Myanmar
- NCLT
- NEPAL
- News & Updates
- Non-Disclosure Agreement
- Online Gaming
- Patent Act
- Patent Commercialisation
- Patent Fess
- Patent Filing
- patent infringement
- Patent Licensing
- Patent Litigation
- Patent Marketing
- Patent Opposition
- Patent Rule Amendment
- Patents
- Personality rights
- pharma
- Pharma- biotech- Patent Commercialisation
- Pharma/Biotech Patent Litigations
- Pollution
- Posh Act
- Protection of SMEs
- RERA
- Section 3(D)
- Signapore
- Social Media
- Sports Law
- Stamp Duty
- Stock Exchange
- Surrogacy in India
- TAX
- Technology
- Telecom Law
- Telecommunications
- Thailand
- Trademark
- Trademark Infringement
- Trademark Litigation
- Trademark Registration in Foreign
- Traditional Knowledge
- UAE
- Uncategorized
- USPTO
- Vietnam
- WIPO
- Women Empower
Khurana and Khurana win an award from Corporate Intl Magazine
We are pleased to announce that our firm Khurana and Khurana Advocates and IP Attorneys has been chosen as the winner of 2013 Corporate Intl Magazine Legal Award for the category of ‘IP Patents Law Firm of the Year in India’. Since 2005, Corporate Intl has been firmly established as one of the leading monthly … Continue reading Khurana and Khurana win an award from Corporate Intl Magazine
Read more »Multi Time Machine v. Amazon.com
No one can resist shopping online in today’s busy times. Online retailing is one of the low costing and productive methods of earning more profits without much effort put in. Take Amazon for example. Amazon, in a bid to gain potential consumers, display alternative products when they look for the initial product they liked. These … Continue reading Multi Time Machine v. Amazon.com
Read more »Copyfight or Copyright?- An analysis on the legal scenario of parallel importation
On 19 March, 2013, in a closely divided 6-3 judgment in Kirtsaeng v. John Wiley, the U.S. Supreme Court held that copyright law could not be used to prevent parallel importation into USA for works that are made outside USA. The facts of the case are as follows: In 1997, a student named Supap Kirtsaeng, … Continue reading Copyfight or Copyright?- An analysis on the legal scenario of parallel importation
Read more »What is a Priority Date of a Patent of Addition?
This Article would not discuss as to what is a patent of addition, when does it expire etc., answers to which are clearly mentioned in the Indian Patents Act. Briefly to sum up, a Patent of addition can be filed at any time either before or after the grant of a main application for an … Continue reading What is a Priority Date of a Patent of Addition?
Read more »Depository Material
Indian Patents Act provides an applicant to deposit a biological material in support of the Indian patent application. It is an exigent via which an applicant can cure what might otherwise be a conceivably fatal defect in a patent application or even for an issued patent. A “biological deposit” can, in that case, fulfil the … Continue reading Depository Material
Read more »Trade Mark Parody- An analysis of Tata Sons v. Greenpeace
Trade Mark Parody is a defense to Trade Mark infringement. There should be no likelihood of confusion between the original host work and the parody work, as the parody will not be taken in a serious manner. It must be cleverly portrayed so as to show itself as a humorous take on the original work. … Continue reading Trade Mark Parody- An analysis of Tata Sons v. Greenpeace
Read more »Competition Law and IPR- Friends or Foes?
An intellectual property right holder is granted legal rights to protect his intellectual property- here is where competition law plays a huge role by ensuring that such power and monopoly is restricted in the market. Both intellectual property rights and competition law have co-existed separately and peacefully since a number of years. It was later … Continue reading Competition Law and IPR- Friends or Foes?
Read more »Analysis of the Intellectual Property Rights (Imported Goods) Enforcement Rules, 2007
The Customs Act, 1962 prohibits import of those goods that infringed intellectual property. Under Section 11, the Central Government can prohibit import or export of goods that infringed patents, trademarks or copyrights, by issuing a notification. It also covered prevention of contravention of any law for the time being in force. Further, Section 111 and … Continue reading Analysis of the Intellectual Property Rights (Imported Goods) Enforcement Rules, 2007
Read more »Smart Strategizing – Protection by shielding through Patent Evergreening in Pharmaceutical Domain with special reference to Roche v Cipla
17th January, 2013 - 1:20 pm
Categories:
IP Practice in India
News & Updates
Pharma/Biotech Patent Litigations
0 Comments
Pankaj Mohanta, an intern at Khurana and Khurana talks about patent evergreening in the pharmaceutical domain. Through this post, he gives special emphasis on the recent landmark case of Roche v Cipla, which created quite a stir in the pharmaceutical industry. Needless to say, patent evergreening is that territory which falls in a bit of … Continue reading Smart Strategizing – Protection by shielding through Patent Evergreening in Pharmaceutical Domain with special reference to Roche v Cipla
Read more »Two International Symposiums on Patent Portfolio Management Strategies for Pharma and Biotech Industry, (i) for R&D Scientists and IP Professionals, and (ii) for Business Development and Licensing Professionals (running concurrently)
About the Symposiums: These Symposiums feature presentation of all important patent issues, as mentioned in the brochure, related to two different groups i.e. Business Development and Licensing Professionals on one hand and R&D Scientists & IP Professionals on the other hand. Both these symposiums for different groups would run concurrently in the different Conference Halls … Continue reading Two International Symposiums on Patent Portfolio Management Strategies for Pharma and Biotech Industry, (i) for R&D Scientists and IP Professionals, and (ii) for Business Development and Licensing Professionals (running concurrently)
Read more »